The Growing Prevalence of Chronic Pain is Driving the Global Opioids Drugs Market at a CAGR of 2.52% by 2027
Browse 36 market data Tables and 25 Figures spread through 147 Pages and in-depth analysis on Global Opioids Drugs market by Product (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, Other products), Application (Pain relief (Cancer pain, Postoperative pain management, Low back pain, Orthopedic, Neuropathic, Fibromyalgia), Anesthesia, Cough suppression, Diarrhea suppression, De-addiction) and by Geography.
This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World, the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.
Opioids Drugs market scenario
The increasing road accidents and surgical procedures, escalating palliative care for patients suffering intensely, usage of abuse-deterrent formulations to restrict the opioid abuse and the growing occurrence of chronic pain are the core drivers that are helping the Global Opioids Drugs market to proliferate further.
The Opioids Drugs market report provides data tables, includes charts and graphs for visual analysis.
Request Free Sample Report for Global Opioids Drugs market by Products, Applications & Geography. https://www.inkwoodresearch.com/reports/global-opioids-drug-market-forecast-2019-2027/#request-free-sample
Market Segmentation
On the basis of Product, the Global Opioids Drugs market is segmented as follows:
- Buprenorphine
- Fentanyl
- Hydrocodone
- Morphine
- Oxycodone
- Tramadol
- Other products
On the basis of Application, the Global Opioids Drugs market is segmented as follows:
- Pain relief
- Cancer pain
- Postoperative pain management
- Low back pain
- Orthopedic
- Neuropathic
- Fibromyalgia
- Anesthesia
- Cough suppression
- Diarrhea suppression
- De-addiction
Report Highlights
– The report provides a detailed analysis of current and future market trends to identify the investment opportunities
– Market forecasts till 2027, using estimated market values as the base numbers
– Key market trends across the business segments, regions and countries
– Key developments and strategies observed in the market
– Market dynamics such as drivers, restraints, opportunities and other trends
– In-depth company profiles of key players and upcoming prominent players
– Growth prospects among the emerging nations through 2027
Companies Profiled
– ACURA PHARMACEUTICALS, INC.
– ALLERGAN PLC
– BIODELIVERY SCIENCES INTERNATIONAL, INC.
– CIPHER PHARMACEUTICALS INC.
– COLLEGIUM PHARMACEUTICAL, INC.
– DAIICHI SANKYO, INC.
– EGALET CORP.
– HIKMA PHARMACEUTICALS PLC
– INDIVIOR INC.
– INSYS THERAPEUTICS, INC.
– JANSSEN PHARMACEUTICALS, INC.
– JOHNSON & JOHNSON
– LANNETT CO. INC.
– LUPIN LTD.
– MYLAN NV
– PFIZER INC.
– PURDUE PHARMA LP
– SANOFI-AVENTIS S.A.
– SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
– TEVA PHARMACEUTICAL INDUSTRIES LTD.
Related Reports
Atopic Dermatitis Drugs market–Global Atopic Dermatitis Drugs market is estimated to grow with approx. 4.77% CAGR during the year 2019-2027.
Pain Management Drugs market – Global Pain Management Drugs market is expected to grow at a 3.88% CAGR during the forecast period.
Hyperphosphatemia Drugs market– The Global Hyperphosphatemia Drugs market is expected to grow at a CAGR of 16.13% between the forecast periods of 2019-2027.
Media Contact
Company Name: Inkwood Research
Contact Person: Clive Cooper
Email: Send Email
Phone: +1 857-302-4704
City: Boston
State: MA
Country: United States
Website: https://www.inkwoodresearch.com/
